Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR Wild-Type Lung Cancer: When There Is a Target, There Is a Targeted Drug

Zhou Fei; Chen Xiaoxia; Zhou Caicun

首页> 外文期刊>Journal of Clinical Oncology >Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR Wild-Type Lung Cancer: When There Is a Target, There Is a Targeted Drug

【24h】

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR Wild-Type Lung Cancer: When There Is a Target, There Is a Targeted Drug

机译：表皮生长因子受体酪氨酸激酶抑制剂在EGFR野生型肺癌患者中的应用：当有靶标时，就有针对性药物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2015年第5期|共3页
作者
Zhou Fei; Chen Xiaoxia; Zhou Caicun;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR Wild-Type Lung Cancer: When There Is a Target, There Is a Targeted Drug [J] . Zhou Fei, Chen Xiaoxia, Zhou Caicun Journal of Clinical Oncology . 2015,第5期

机译：表皮生长因子受体酪氨酸激酶抑制剂在EGFR野生型肺癌患者中的应用：当有靶标时，就有针对性药物
2. Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors [J] . Myung Hee Chang MD, Hee Kyung Ahn MD, Jeeyun Lee MD PhD, Cancer . 2011,第1期

机译：EGFR-酪氨酸激酶抑制剂治疗表皮生长因子受体（EGFR）野生型非小细胞肺癌患者双调蛋白表达的临床影响
3. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non-Small-Cell Lung Cancer: The Never-Ending Story. [J] . Francesco Gelsomino, Francesco Agustoni, Monica Niger, Journal of Clinical Oncology . 2013,第26期

机译：表皮生长因子受体酪氨酸激酶抑制剂在EGFR野生型非小细胞肺癌患者中的治疗：永无止境的故事。
4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer [O] . -1

机译：表皮生长因子受体突变（EGFR）测试为应对预测EGFR靶向酪氨酸激酶抑制剂（TKI）治疗药物与晚期非小细胞肺癌
7. Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors [O] . Myung Hee Chang, Hee Kyung Ahn, Jeeyun Lee, 2010

机译：EGFR-酪氨酸激酶抑制剂治疗表皮生长因子受体（EGFR）野生型NONSMALL细胞肺癌患者临床影响

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR Wild-Type Lung Cancer: When There Is a Target, There Is a Targeted Drug

著录项

相似文献

相关主题

期刊订阅